Society of Urologic Oncology Biotechnology Forum: new approaches and targets for advanced prostate cancer.
We provide an overview of advances in molecular based therapeutic strategies for prostate cancer and summarize the studies presented at the Society of Urologic Oncology Biotechnology Forum in 2000. Three promising new treatment strategies are presented, and a critique of the advantages and limitations of each is offered by a leading expert in the field. Treatment results and the current state of dendritic cell based immunotherapy, monoclonal antibody therapy and anti-apoptotic treatment approaches are presented. Currently patients with advanced prostate carcinoma have expanded therapeutic options available in the form of molecular based phases II and III clinical trials.